GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Protara Therapeutics Inc (FRA:1KPA) » Definitions » Accounts Payable

Protara Therapeutics (FRA:1KPA) Accounts Payable : €4.23 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Protara Therapeutics Accounts Payable?

Protara Therapeutics's Accounts Payable for the quarter that ended in Dec. 2024 was €4.23 Mil.

Protara Therapeutics's quarterly Accounts Payable increased from Jun. 2024 (€1.29 Mil) to Sep. 2024 (€2.07 Mil) and increased from Sep. 2024 (€2.07 Mil) to Dec. 2024 (€4.23 Mil).

Protara Therapeutics's annual Accounts Payable increased from Dec. 2022 (€1.50 Mil) to Dec. 2023 (€2.23 Mil) and increased from Dec. 2023 (€2.23 Mil) to Dec. 2024 (€4.23 Mil).


Protara Therapeutics Accounts Payable Historical Data

The historical data trend for Protara Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Protara Therapeutics Accounts Payable Chart

Protara Therapeutics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial 0.75 0.84 1.50 2.23 4.23

Protara Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.23 0.89 1.29 2.07 4.23

Protara Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Protara Therapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of Protara Therapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Protara Therapeutics Business Description

Traded in Other Exchanges
Address
345 Park Avenue South, 3rd Floor, New York, NY, USA, 10010
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

Protara Therapeutics Headlines

No Headlines